We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.15B
AUM Growth
+$134M
Cap. Flow
-$171M
Cap. Flow %
-2.39%
Top 10 Hldgs %
39.4%
Holding
139
New
7
Increased
31
Reduced
89
Closed
4

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$234M
2
VLO icon
Valero Energy
VLO
+$81.7M
3
TIF
Tiffany & Co.
TIF
+$53M
4
CXW icon
CoreCivic
CXW
+$42M
5
COST icon
Costco
COST
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 14.77%
2 Consumer Discretionary 13.82%
3 Communication Services 11.81%
4 Industrials 11.19%
5 Materials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARE icon
101
Alexandria Real Estate Equities
ARE
$9B
$3.87M 0.05%
49,840
-2,147
-4% -$161K
QCOM icon
102
Qualcomm
QCOM
$156B
$3.71M 0.05%
46,793
-26,282
-36% -$2.09M
CIG icon
103
CEMIG Preferred Shares
CIG
$6.26B
$3.56M 0.05%
873,919
-320,490
-27% -$1.22M
CBRE icon
104
CBRE Group
CBRE
$42.7B
$3.45M 0.05%
107,663
-26,624
-20% -$769K
AFL icon
105
Aflac
AFL
$65.1B
$3.43M 0.05%
110,070
+9,764
+10% +$305K
IBM icon
106
IBM
IBM
$207B
$3.31M 0.05%
19,130
-9,292
-33% -$1.67M
ACC
107
DELISTED
American Campus Communities, Inc.
ACC
$3.27M 0.05%
85,582
-3,709
-4% -$142K
CPT icon
108
Camden Property Trust
CPT
$11B
$3.11M 0.04%
43,730
-1,867
-4% -$130K
FRT icon
109
Federal Realty Investment Trust
FRT
$10.8B
$2.91M 0.04%
24,049
-5,101
-17% -$602K
IFGL icon
110
iShares International Developed Real Estate ETF
IFGL
$82.7M
$2.69M 0.04%
83,869
-300
-0.4% -$9.43K
TIP icon
111
iShares TIPS Bond ETF
TIP
$14.5B
$2.51M 0.04%
21,745
-200
-0.9% -$22.8K
HMSY
112
DELISTED
HMS Holdings Corp.
HMSY
$2.37M 0.03%
116,300
-60,700
-34% -$1.09M
DOC icon
113
Healthpeak Properties
DOC
$15.1B
$2.32M 0.03%
61,574
-15,389
-20% -$579K
KIM icon
114
Kimco Realty
KIM
$17.2B
$2.11M 0.03%
91,948
-4,037
-4% -$91.7K
AIV
115
Aimco
AIV
$384M
$2.1M 0.03%
487,357
-91,951
-16% -$381K
TCO
116
DELISTED
Taubman Centers Inc.
TCO
$2.04M 0.03%
26,863
-1,635
-6% -$120K
RSX
117
DELISTED
VanEck Russia ETF
RSX
$2M 0.03%
76,000
-14,000
-16% -$344K
CZZ
118
DELISTED
Cosan Limited
CZZ
$1.97M 0.03%
145,000
-4,000
-3% -$50.9K
FLEX icon
119
Flex
FLEX
$41.9B
$1.96M 0.03%
234,371
-53,267
-19% -$401K
ITUB icon
120
Itaú Unibanco
ITUB
$93.6B
$1.93M 0.03%
334,248
-141,645
-30% -$834K
TIMB icon
121
TIM SA
TIMB
$9.22B
$1.89M 0.03%
65,000
-10,000
-13% -$273K
WPG
122
DELISTED
Washington Prime Group Inc.
WPG
$1.7M 0.02%
+10,050
New +$1.75M
INFY icon
123
Infosys
INFY
$48.5B
$1.65M 0.02%
245,544
DEI icon
124
Douglas Emmett
DEI
$1.99B
$1.49M 0.02%
52,636
-12,991
-20% -$362K
EEM icon
125
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$1.49M 0.02%
34,355

Similar funds

Sarasin & Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Sarasin & Partners held 139 positions worth $7.15B, up 1.9% from $7.01B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sarasin & Partners's Q2 2014 filing shows 7 new, 31 increased, 89 reduced and 4 closed positions. Its largest new stake was Tata Motors Limited: 1,525,538 shares worth $59.6M. The largest sale was Pfizer, an estimated $234M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Sarasin & Partners's largest Q2 2014 buy was Tata Motors Limited: 1,525,538 shares worth $59.6M.
  • Sarasin & Partners added most to Anadarko Petroleum in Q2 2014, an estimated $111M increase.
  • Sarasin & Partners's biggest Q2 2014 reduction was Pfizer, cutting an estimated $234M.
  • Sarasin & Partners fully exited CATAMARAN CORP COM STK (CDA) in Q2 2014, selling an estimated $4.94M.
  • Sarasin & Partners's ten largest holdings make up 39% of its $7.15B portfolio in Q2 2014.
  • Sarasin & Partners opened 7 new positions and closed 4 in Q2 2014.
  • Sarasin & Partners's portfolio value rose 1.9% quarter-over-quarter to $7.15B.

Based on Sarasin & Partners's 13F filing for Q2 2014, filed 14 Jul 2014.